NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/03/2026
Voltar para busca
Dado oficial do USPTO
WHERE HUMAN INTELLIGENCE MEETS ARTIFICIAL INTELLIGENCE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
WHERE HUMAN INTELLIGENCE MEETS ARTIFICIAL INTELLIGENCE
ST13
US500000098724021Classe
35, 42
Pedido
98724021
Registro
8156152
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
24
Atualização mais recente
03/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42
Data de depósito
29/08/2024
Data de registro
03/03/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/03/2026
Última transação
03/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
2024-01-00
Primeiro uso no comércio
2024-01-00
Código do desenho
4
Tipo de titular
16
Localização do titular
Rockville, MD, US
Examinador
FICKES, JERI J
Unidade examinadora
L70
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
The Emmes Company, LLC
Representantes
John P. McCormick Fish & Richardson P.C.
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Data processing servicesdata reporting and data collection of health studies in the field of biomedical research for business purposes; Business management consulting; Business consulting and information services; Business assistanceadvisory and consulting services relating to business program and project management in the fields of clinical trialsbusiness training and educationbusiness management consultingstaff augmentation; Technical consultation in the field of business process re-engineering services; Compiling and analyzing statisticsdataother sources of information for business purposes; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of pharmaceuticalmedicalhealthcarelife sciences companies to assist them with clinical researchclinical trials and applications for drugbiologic and device approval; Providing independent review of clinical trials for business purposes; Maintaining a registry of patientscompilation of patient information into computer databases; Recruitment servicesadvertising clinical trialsrecruiting patientsplacing patients for participation in clinical trials for testing of drugsbiologics and devices; Business services provided to the healthcaremedicallife sciencespharmaceuticalclinical trial industriesthe collectionreportinganalysis of quality data for business purposes; Providing statistical analysis and research of biomedicalmedicalhealthcareclinical triallife sciencespharmaceutical data and information for business purposes
Classe 42
Biomedical research services consisting of protocol design and collecting information obtained in the research for scientific purposes; Providing online non-downloadable software featuring software for data captureanalysisreportingmanagement in the field of biomedicalmedicalhealthcareclinical triallife sciencespharmaceutical research; Providing statistical analysis and research of biomedicalmedicalhealthcareclinical triallife sciencespharmaceutical data and information for scientific purposes; Providing medical and scientific research in the field of clinical trials; Consulting services for others in the field of designplanningimplementationoptimization of clinical trials; Providing online non-downloadable software and providing a website featuring online non-downloadable software using artificial intelligence that enables users to conduct regulatory compliant clinical trials; Providing online non-downloadable software and providing a website featuring online non-downloadable software that enables users to conduct regulatory compliant clinical trials by creating case report forms for clinical trialsgenerating compliance and performance reportsmanaging clinical data and specimensmonitoring and tracking clinical trial audit activitiesreviewing and auditing clinical trial dataaccessing clinical trial standard setting resources; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for conducting clinical trials; Consulting in the field of IT project management; Planningdesignmanagement of information technology systems; Software integration services in the nature of integration of computer software into multiple systems and networks; Technological consultation in the field of machine engineering analysis; Computer system design and software engineering services; Providing engineering and engineering consulting services relating to computer network and computer software systems integrationtestingevaluation in the field of environmental engineering; Information technology consulting services relating to computer network and software design for the healthcaremedicallife sciencesclinical trial industries; Information technology project management servicesconsulting in the field of information technology project management relating to computer network and software design and the installationmaintenance and repair of computer software; Scientific researchdevelopmentconsulting services; Clinical researchclinical testinglaboratory testing services in the pharmaceuticalmedicalhealthcarelife sciences fields; Product development consultation in the pharmaceuticalmedicalhealthcareclinical triallife sciences fields; Medical and scientific researchconducting clinical trials for others; Providing temporary use of onlinenon-downloadable computer software for collectingmanaginganalyzing clinical trial data; Providing an on-line interactive database featuring scientific and medical research information in the pharmaceuticalmedicalhealthcarelife sciences fields; Providing scientificmedicalclinical trial information relating to the developmentvalidationregulatory approval of pharmaceutical drugsbiologicsmedical devices; Providing technical information relating to the development and validation of pharmaceutical drugsbiologicsmedical devices; Providing online non-downloadable software for data and information collectionautomationcorrectionmonitoringanonymizationintegrationreportingtrackinganalysis in the medicalhealthcareclinical trialpharmaceuticallife sciences fields; Providing online non-downloadable software for customer relationship management and patient relationship management
Publicações
Histórico de despachos e eventos da marca no USPTO.
24 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
03/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/01/2026
PUBO
PUBLISHED FOR OPPOSITION
13/01/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/01/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/12/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
15/12/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
15/12/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
15/12/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
15/12/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
24/09/2025
GNFR
FINAL REFUSAL E-MAILED
24/09/2025
CNFR
FINAL REFUSAL WRITTEN
24/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/09/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/09/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/09/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
13/06/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
13/06/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/03/2025
GNRT
NON-FINAL ACTION E-MAILED
18/03/2025
CNRT
NON-FINAL ACTION WRITTEN
18/03/2025
DOCK
ASSIGNED TO EXAMINER
13/03/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/03/2025
NWAP
NEW APPLICATION ENTERED
29/08/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace WHERE HUMAN INTELLIGENCE MEETS ARTIFICIAL INTELLIGENCE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.